Trial Outcomes & Findings for Preventing Violence Among Veterans in Substance Use Disorder Treatment (NCT NCT01337973)

NCT ID: NCT01337973

Last Updated: 2019-09-06

Results Overview

The CTS-SI is a semi-structured interview assessing interpersonal violence (violence severity, injury and characteristics of interpersonal conflict incidents). Baseline data collection assessed the 180 days prior to enrollment, and follow-up data was collected at 3 and 6 months for the prior 90 days, and at 12 months for the past 180 days. The analysis below compares the month rate of various types of interpersonal aggression from the period pre-baseline to the monthly rate post-intervention (across all 12 months of follow-up) in the form of % difference. Means at baseline, 3 , 6 and 12 months were compared resulting in a number with no measure of dispersion. Values were calculated across all participants. There were primary aggression outcomes (overall physical aggression, injuring another person), and secondary aggression outcomes (partner physical aggression and injury, nonpartner physical aggression and injury).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

180 participants

Primary outcome timeframe

% difference between baseline and the collapsed 3-, 6-, and 12-month follow-up data

Results posted on

2019-09-06

Participant Flow

Participants were recruited from June 2012-June 2015 from outpatient VA mental health programs (Substance Use Disorder, Substance use Disorder Intensive Outpatient, General Mental Health).

Of 1097 eligible for screening, 183 refused participation (17%), 75 (7%) were missed and 839 completed the screening assessment. Of those completing screening, 639 were not eligible for the RCT and 20 refused further participation. Thus, 180 out of 200 eligible veterans (90%) were randomized to one of the three treatment conditions.

Participant milestones

Participant milestones
Measure
Arm 1: MI-CBT
MI-CBT (six sessions during acute treatment phase integrating motivational interviewing and cognitive behavioral approaches) MI-CBT: Six individual psychotherapy sessions during the acute substance use disorder treatment phase integrating motivational interviewing and cognitive behavioral approaches
Arm 2: MI-CBT+CC
MI-CBT+CC (acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention) MI-CBT+CC: Acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention
Arm 3: E-TAU
E-TAU (enhanced treatment as usual - includes brief session and provision of resources) E-TAU: Enhanced Treatment as Usual
Overall Study
STARTED
60
60
60
Overall Study
COMPLETED
44
45
49
Overall Study
NOT COMPLETED
16
15
11

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm 1: MI-CBT
MI-CBT (six sessions during acute treatment phase integrating motivational interviewing and cognitive behavioral approaches) MI-CBT: Six individual psychotherapy sessions during the acute substance use disorder treatment phase integrating motivational interviewing and cognitive behavioral approaches
Arm 2: MI-CBT+CC
MI-CBT+CC (acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention) MI-CBT+CC: Acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention
Arm 3: E-TAU
E-TAU (enhanced treatment as usual - includes brief session and provision of resources) E-TAU: Enhanced Treatment as Usual
Overall Study
Lost to Follow-up
2
4
3
Overall Study
Death
1
2
1
Overall Study
Withdrawal by Subject
10
8
4
Overall Study
missing data on primary outcome
3
1
3

Baseline Characteristics

Preventing Violence Among Veterans in Substance Use Disorder Treatment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm 1: MI-CBT
n=60 Participants
MI-CBT (six sessions during acute treatment phase integrating motivational interviewing and cognitive behavioral approaches) MI-CBT: Six individual psychotherapy sessions during the acute substance use disorder treatment phase integrating motivational interviewing and cognitive behavioral approaches
Arm 2: MI-CBT+CC
n=60 Participants
MI-CBT+CC (acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention) MI-CBT+CC: Acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention
Arm 3: E-TAU
n=60 Participants
E-TAU (enhanced treatment as usual - includes brief session and provision of resources) E-TAU: Enhanced Treatment as Usual
Total
n=180 Participants
Total of all reporting groups
Age, Continuous
39.9 years
STANDARD_DEVIATION 12.9 • n=93 Participants
44.9 years
STANDARD_DEVIATION 12.9 • n=4 Participants
42.9 years
STANDARD_DEVIATION 12.8 • n=27 Participants
42.6 years
STANDARD_DEVIATION 13.0 • n=483 Participants
Sex: Female, Male
Female
5 Participants
n=93 Participants
5 Participants
n=4 Participants
5 Participants
n=27 Participants
15 Participants
n=483 Participants
Sex: Female, Male
Male
55 Participants
n=93 Participants
55 Participants
n=4 Participants
55 Participants
n=27 Participants
165 Participants
n=483 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=93 Participants
2 Participants
n=4 Participants
2 Participants
n=27 Participants
6 Participants
n=483 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
55 Participants
n=93 Participants
55 Participants
n=4 Participants
57 Participants
n=27 Participants
167 Participants
n=483 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants
n=93 Participants
3 Participants
n=4 Participants
1 Participants
n=27 Participants
7 Participants
n=483 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
1 Participants
n=4 Participants
0 Participants
n=27 Participants
1 Participants
n=483 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Race (NIH/OMB)
Black or African American
14 Participants
n=93 Participants
18 Participants
n=4 Participants
19 Participants
n=27 Participants
51 Participants
n=483 Participants
Race (NIH/OMB)
White
41 Participants
n=93 Participants
35 Participants
n=4 Participants
38 Participants
n=27 Participants
114 Participants
n=483 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
n=93 Participants
6 Participants
n=4 Participants
3 Participants
n=27 Participants
14 Participants
n=483 Participants
Region of Enrollment
United States
60 Participants
n=93 Participants
60 Participants
n=4 Participants
60 Participants
n=27 Participants
180 Participants
n=483 Participants

PRIMARY outcome

Timeframe: % difference between baseline and the collapsed 3-, 6-, and 12-month follow-up data

Population: Main analyses used General Estimating Equations which accounts for missing data. Results in tables below are from bivariate analyses.

The CTS-SI is a semi-structured interview assessing interpersonal violence (violence severity, injury and characteristics of interpersonal conflict incidents). Baseline data collection assessed the 180 days prior to enrollment, and follow-up data was collected at 3 and 6 months for the prior 90 days, and at 12 months for the past 180 days. The analysis below compares the month rate of various types of interpersonal aggression from the period pre-baseline to the monthly rate post-intervention (across all 12 months of follow-up) in the form of % difference. Means at baseline, 3 , 6 and 12 months were compared resulting in a number with no measure of dispersion. Values were calculated across all participants. There were primary aggression outcomes (overall physical aggression, injuring another person), and secondary aggression outcomes (partner physical aggression and injury, nonpartner physical aggression and injury).

Outcome measures

Outcome measures
Measure
Arm 1: MI-CBT
n=60 Participants
MI-CBT (six sessions during acute treatment phase integrating motivational interviewing and cognitive behavioral approaches) MI-CBT: Six individual psychotherapy sessions during the acute substance use disorder treatment phase integrating motivational interviewing and cognitive behavioral approaches
Arm 2: MI-CBT+CC
n=60 Participants
MI-CBT+CC (acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention) MI-CBT+CC: Acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention
Arm 3: E-TAU
n=60 Participants
E-TAU (enhanced treatment as usual - includes brief session and provision of resources) E-TAU: Enhanced Treatment as Usual
Conflict Tactics Scale-Structured Interview (CTS-SI)
Overall physical aggression % change from baseline
-90 percentage change
-90 percentage change
-94 percentage change
Conflict Tactics Scale-Structured Interview (CTS-SI)
Overall Injury Perpetration % change from baseline
-82 percentage change
-91 percentage change
-86 percentage change
Conflict Tactics Scale-Structured Interview (CTS-SI)
Partner physical aggression % change from baseline
-92 percentage change
-91 percentage change
-97 percentage change
Conflict Tactics Scale-Structured Interview (CTS-SI)
Partner injury % change from baseline
-100 percentage change
-85 percentage change
-61 percentage change
Conflict Tactics Scale-Structured Interview (CTS-SI)
Nonpartner physical aggresion % change from baseli
-88 percentage change
-89 percentage change
-90 percentage change
Conflict Tactics Scale-Structured Interview (CTS-SI)
Nonpartner injury % change from baseline
-76 percentage change
-93 percentage change
-99 percentage change

SECONDARY outcome

Timeframe: % difference between baseline and the collapsed 3-, 6-, and 12-month follow-up data

Population: Main analyses used General Estimating Equations which accounts for missing data. Results in data table are from bivariate analyses.

Data was collected via a Time-line Follow Back interview. Semi-structured interview assessing alcohol and drug use. Baseline data collection assessed the 180 days prior to enrollment, and follow-up data was collected at 3 and 6 months for the prior 90 days, and at 12 months for the past 180 days. The analysis below compares the monthly rate of various types of substance use (heavy drinking, cocaine, marijuana, and illicit) from the period pre-baseline to the monthly rate post-intervention (across all 12 months of follow-up) in the form of % difference. (% days use for each substance) Means at baseline, 3 , 6 and 12 months were compared resulting in a number with no measure of dispersion. Values were calculated across all participants.

Outcome measures

Outcome measures
Measure
Arm 1: MI-CBT
n=60 Participants
MI-CBT (six sessions during acute treatment phase integrating motivational interviewing and cognitive behavioral approaches) MI-CBT: Six individual psychotherapy sessions during the acute substance use disorder treatment phase integrating motivational interviewing and cognitive behavioral approaches
Arm 2: MI-CBT+CC
n=60 Participants
MI-CBT+CC (acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention) MI-CBT+CC: Acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention
Arm 3: E-TAU
n=60 Participants
E-TAU (enhanced treatment as usual - includes brief session and provision of resources) E-TAU: Enhanced Treatment as Usual
Percent Change in the Percentage of Days of Substance Use for Each Substance
Heavy Drinking % change from baseline
-68 percentage of change
-59 percentage of change
-55 percentage of change
Percent Change in the Percentage of Days of Substance Use for Each Substance
cocaine use % change from baseline
-83 percentage of change
-86 percentage of change
-56 percentage of change
Percent Change in the Percentage of Days of Substance Use for Each Substance
marijuana use % change from baseline
-40 percentage of change
-42 percentage of change
-44 percentage of change
Percent Change in the Percentage of Days of Substance Use for Each Substance
Overall illicit drug use % change from baseline
-52 percentage of change
-50 percentage of change
-57 percentage of change

Adverse Events

Arm 1: MI-CBT

Serious events: 1 serious events
Other events: 0 other events
Deaths: 1 deaths

Arm 2: MI-CBT+CC

Serious events: 2 serious events
Other events: 0 other events
Deaths: 2 deaths

Arm 3: E-TAU

Serious events: 1 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
Arm 1: MI-CBT
n=60 participants at risk
MI-CBT (six sessions during acute treatment phase integrating motivational interviewing and cognitive behavioral approaches) MI-CBT: Six individual psychotherapy sessions during the acute substance use disorder treatment phase integrating motivational interviewing and cognitive behavioral approaches
Arm 2: MI-CBT+CC
n=60 participants at risk
MI-CBT+CC (acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention) MI-CBT+CC: Acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention
Arm 3: E-TAU
n=60 participants at risk
E-TAU (enhanced treatment as usual - includes brief session and provision of resources) E-TAU: Enhanced Treatment as Usual
Social circumstances
Participant Death
1.7%
1/60 • Number of events 1
In the event of participant death, cause of death is unknown.
3.3%
2/60 • Number of events 2
In the event of participant death, cause of death is unknown.
1.7%
1/60 • Number of events 1
In the event of participant death, cause of death is unknown.

Other adverse events

Adverse event data not reported

Additional Information

Stephen Chermack, Ph.D.

VA Ann Arbor

Phone: 734 845-5046

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place